Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fevzi Altuntas

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|April 27, 2026
Outcomes of Brentuximab Vedotin Monotherapy in Refractory/Relapsed Classical Hodgkin's Lymphoma: A Multi-Center Retrospective Study on Survival and SafetyMehmet Bakirtas, Ipek Yonal Hindilerden, Bahar Uncu Ulu, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|March 6, 2018
A multicenter experience of thrombotic microangiopathies in Turkey: The Turkish Hematology Research and Education Group (ThREG)-TMA01 studyEmre Tekgündüz, Mehmet Yılmaz, Mehmet Ali Erkurt, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 11, 2021
The Real-World Experience With Single Agent Ibrutinib in Relapsed/Refractory CLLSeval Akpinar, Mehmet Hilmi Dogu, Serhat Celik, et al.
Annals of Hematology|June 9, 2020
Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experienceHuseyin Bekoz, Murat Ozbalak, Nuri Karadurmus, et al.
Nature Biomedical Engineering|November 29, 2025
mRNA engineering of allogeneic mesenchymal stem cells enables coordinated delivery of T cell engagers and immunotherapeutic cuesC Andrew Stewart, Shaji Daniel, Elizabeth J Curvino, et al.
Hematological Oncology|June 25, 2021
Brentuximab vedotin consolidation therapy after autologous stem-cell transplantation in patients with high-risk Hodgkin lymphoma: Multicenter retrospective studyOlga Meltem Akay, Murat Ozbalak, Mustafa Pehlivan, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|February 26, 2023
International Forum: The Turkish perspective on apheresis activity: The Turkish apheresis registry reportDuzgun Ozatli, Aslı Odabaşı Giden, Mehmet Ali Erkurt, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 1, 2019
The Turkish experience with therapeutic plasma exchange: A national surveySerdal Korkmaz, Serife Solmaz Medeni, Fatih Demirkan, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|April 27, 2026
Outcomes of Brentuximab Vedotin Monotherapy in Refractory/Relapsed Classical Hodgkin's Lymphoma: A Multi-Center Retrospective Study on Survival and SafetyMehmet Bakirtas, Ipek Yonal Hindilerden, Bahar Uncu Ulu, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|March 6, 2018
A multicenter experience of thrombotic microangiopathies in Turkey: The Turkish Hematology Research and Education Group (ThREG)-TMA01 studyEmre Tekgündüz, Mehmet Yılmaz, Mehmet Ali Erkurt, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 11, 2021
The Real-World Experience With Single Agent Ibrutinib in Relapsed/Refractory CLLSeval Akpinar, Mehmet Hilmi Dogu, Serhat Celik, et al.
Annals of Hematology|June 9, 2020
Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experienceHuseyin Bekoz, Murat Ozbalak, Nuri Karadurmus, et al.
Nature Biomedical Engineering|November 29, 2025
mRNA engineering of allogeneic mesenchymal stem cells enables coordinated delivery of T cell engagers and immunotherapeutic cuesC Andrew Stewart, Shaji Daniel, Elizabeth J Curvino, et al.
Hematological Oncology|June 25, 2021
Brentuximab vedotin consolidation therapy after autologous stem-cell transplantation in patients with high-risk Hodgkin lymphoma: Multicenter retrospective studyOlga Meltem Akay, Murat Ozbalak, Mustafa Pehlivan, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|February 26, 2023
International Forum: The Turkish perspective on apheresis activity: The Turkish apheresis registry reportDuzgun Ozatli, Aslı Odabaşı Giden, Mehmet Ali Erkurt, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 1, 2019
The Turkish experience with therapeutic plasma exchange: A national surveySerdal Korkmaz, Serife Solmaz Medeni, Fatih Demirkan, et al.
Pageof 9